Vaccines East Asia 2020
Vaccines East Asia promises to be an opportunity to network with vaccine companies from both developed and developing countries, industry leaders, regulatory officials, academia and vaccine players worldwide.
Meet key stakeholders in both developed and developing countries, industry leaders, vaccine players and academia in this year’s biologics market of the world. If Vaccine East Asia is what you are interested in, this is where you have to be!
Leverage on this year’s best marketing and sales opportunity to access the fastest growing biologics market of the world! Vaccine East Asia 2020 will be attended by decision-makers who will influence the future of Asia’s vaccines industry. Your potential clients and partners are hungry for new vaccines technologies and services, and they need you to make it happen. Be there and be seen!
eBook: Christoph Conrad Presentation
eBook - Directory Of Recently Approved Vaccines
eBook - Pipelines of Asia's Vaccine Manufacturers
Korea is in a unique position in terms of biopharmaceutical development. The Korean government has proposed to become the seventh-largest of the total global market by 2020! According to a report by GlobalData, the Korea’s Biopharmaceutical market is expected to rise to reach $20.4 billion in value by 2020. Korea’s biopharmaceutical market was worth about $2.3 billion in 2017, accounting for 12.8% share of the Korea’s pharmaceutical market worth $18.0 billion as of 2017. (Source: MFDS Yearbook 2018).